FDA Inspection 1255016 — Nanospectra Bioscience Inc
The FDA completed an inspection of Nanospectra Bioscience Inc on Nov 22, 2024 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 2946 | 21 CFR 812.45 | Sponsor provide device information to investigators |
| 7006 | 21 CFR 812.43(c)(5) | No financial disclosure info in investigator agreement |